UTI Treatment: Antibiotics, Symptom Relief & Prevention Strategies

Urinary Tract Infection (UTI): Evidence-Based Treatment

UTIs are typically bacterial (E. coli 75–90%). Treatment: targeted antibiotics + supportive care.

First-Line Antibiotics (Uncomplicated Cystitis, Women)

Alternative / Complicated UTI Agents

  • Fluoroquinolones (cipro, levo) – reserve; resistance, tendinitis, aortic risk
  • Beta-lactams (amox-clav, cefdinir) – less effective, more resistance
  • IV agents (ceftriaxone, ertapenem) – pyelonephritis, sepsis

Symptom Management

  • Phenazopyridine: Urinary analgesic (200 mg TID × 2 days max); orange urine
  • NSAIDs: Ibuprofen for dysuria/inflammation (may reduce antibiotic need in mild cases)
  • Hydration: 2–3 L/day; flushes bacteria
  • Avoid irritants: Caffeine, alcohol, spicy foods

Adjunctive / Preventive

  • Probiotics (Lactobacillus): May reduce recurrence (vaginal > oral)
  • Cranberry (PACs): Mixed evidence; not treatment
  • Vaginal estrogen (postmenopausal): Restores lactobacilli, ↓ UTI 50–75%
  • Behavioral: Void post-coitus, wipe front-back, avoid diaphragms/spermicide

Follow-Up

  • Uncomplicated: No test-of-cure if symptoms resolve
  • Pyelonephritis/complicated: Repeat culture 1–2 wks post-treatment
  • Recurrent (≥3/yr or ≥2/6mo): Urology eval, prophylaxis consideration

Complete the prescribed course. Resistance is driven by incomplete treatment and overuse.

Urinary Disorders - Related Articles

Health Sciences © https://www.222health.com

AgentDose & DurationNotes
Nitrofurantoin100 mg BID × 5 daysLow resistance; concentrates in urine; avoid if CrCl <30
Trimethoprim-sulfamethoxazole (TMP-SMX)160/800 mg BID × 3 daysIf local E. coli resistance <20%
Fosfomycin3 g single doseConvenient; lower efficacy vs. others
Pivmecillinam400 mg TID × 3–7 daysNon-US; excellent stewardship profile